Announcement on Progress in Capital Increase and Debt-to-Share Swap Matters of Zhejiang Dtrm BioPharma Co., Ltd.

About this update from Zhejiang Hisun Pharmaceutical Co., Ltd. Class A

Announcement on Progress in Capital Increase and Debt-to-Share Swap Matters of Zhejiang Dtrm BioPharma Co., Ltd. The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Hisun Pharmaceutical Co., Ltd. Class A